Sanofi-Aventis Acquires Generics Drugmaker in Mexico

Sanofi-Aventis (Paris) says its Sanofi-Aventis Mexico (Mexico City) subsidiary has acquired generic pharmaceutical firm Laboratorios Kendrick (Mexico City), for an undisclosed sum. Sanofi-Aventis says the deal will accelerate its sales growth in emerging markets. Cartier: Accelerating growth. “The Kendrick acquisition represents an exceptional opportunity to accelerate our growth in the generics market in Mexico,” says Nicolas Cartier, general manager of Sanofi-Aventis Mexico. The deal will enable Sanofi-Aventis to “reinforce its leadership in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers